Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Theriva Biologics Inc TOVX

Healthcare Biotechnology
Theriva Biologics, Inc., a clinical-stage company, develops therapeutics to treat cancer and related diseases in areas of high unmet need in the United States. The company’s lead product candidate is VCN-01, a clinical stage oncolytic human adenovirus that is in a Phase 2 clinical study for the treatment of pancreatic cancer; a Phase 1 clinical study for the treatment of retinalblastoma; a... see more

Current News (NYSEAM:TOVX)

Theriva(TM) Biologics Licenses SYN-020 to Rasayana Therapeutics for Multiple Indications

GlobeNewswire February 18, 2026

Theriva(TM) Biologics Announces Upcoming Presentation of Data from VCN-01 Retinoblastoma Phase 1 Clinical Trial at APAO 2026

GlobeNewswire February 3, 2026

Theriva(TM) Biologics Announces Positive Scientific Advice from the European Medicines Agency (EMA) on the Design of a Phase 3 Trial of VCN-01 in Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)

GlobeNewswire December 29, 2025

Theriva(TM) Biologics Reports Third Quarter 2025 Operational Highlights and Financial Results

GlobeNewswire November 12, 2025

Theriva Biologics Provides Response to Unusual Market Action

GlobeNewswire October 24, 2025

Theriva(TM) Biologics Announces a Warrant Inducement Transaction for $4.0 Million in Gross Proceeds

GlobeNewswire October 16, 2025

Theriva(TM) Biologics Announces Upcoming Presentations at Medical Meetings

GlobeNewswire October 13, 2025

Theriva(TM) Biologics Announces Presentation Describing Next Generation Oncolytic Adenovirus VCN-12 at the 32nd Annual Congress of the European Society of Gene & Cell Therapy (ESGCT)

GlobeNewswire October 6, 2025

Theriva(TM) Biologics Reports Second Quarter 2025 Operational Highlights and Financial Results

GlobeNewswire August 11, 2025
View More News ››

Opinion & Analysis (NYSEAM:TOVX)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NYSEAM:TOVX)

TOVX.....Just tapped N.L.O.D

$1.51 How am i doing ?
Iseneschal - October 3, 2024

TOVX.....Dumpfest on the opening bell

Told ya ; )
Iseneschal - October 3, 2024

TOVX.....early a.m runner on NR...set up for P.O ; )

Theriva™ Biologics Announces Positive Outcome of Data and Safety Monitoring Committee (DSMC) Review in Phase 1b/2a Clinical Trial of...
Iseneschal - October 3, 2024

Theriva Biologics, Inc. (TOVX): Advancing Oncology Pipeline

http://beyondspx.com/2024/08/03/theriva-biologics-inc-tovx-advancing-oncology-pipeline-with-promising-vcn-01-data/
MikeTester - August 3, 2024

TOVX..... Volume update at 11:10 p.s.t

490,000 shs have traded since 10:43
Iseneschal - June 28, 2023

TOVX.... This will be a screaming buy if...big if ....

it crosses the $1.06 resistance Me no position unless it does ....with volum e
Iseneschal - June 28, 2023
View more Bullboard ››

FPX Nickel Corp.

FPX Nickel Corp.

FPX Nickel Corp., a junior nickel mining company, engages in the acquisition, exploration, and development of mineral ...
View More »

Podcasts